about
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resourc...
Read More
102.67
5.93
(6.13%)
89,152.6
XNYS Volume
XNYS 04 Jun, 2026 11:15 AM (EDT)
Board Meeting
The next board meeting for Veradermics Inc is on 08 Jun 2026 for the purpose of Goldman Sachs 47th Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Bearish
Veradermics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..